Although the role of this microRNA in CD is not clear, published evidence suggests that TGF-β may activate miR-208a to regulate genes related to hypertrophy, as TGF-β neutralizing antibody therapy attenuated miR-208a induced expression in myocytes (Wang et al., 2013). Here, TGFB1 is linked to Cowden disease.